News Focus
News Focus
Followers 142
Posts 23885
Boards Moderated 0
Alias Born 06/13/2011

Re: Pharmacydude post# 372365

Sunday, 03/06/2022 12:36:05 PM

Sunday, March 06, 2022 12:36:05 PM

Post# of 447411
Pdude. re your comment

they “don’t believe in preventative cardiology” according to Bhatt,



Please provide a link to that comment to verify .
Both poster JF and myself are Kaiser CAD patients ...He is obviously prior event having had an MI and I'm considered secondary prevention having had a cardiac Cath to determine coronary stenosis ( not enough to require stents ) .

Kaiser prescribes brand Vascepa to both of us

The above is the approach I think the UK/EU will go with reimbursement

Kaiser probably doesn't cover for primary prevention ...but remember most in R-IT were secondary prevention / prior event patients ( from memory ) .

The data April 3rd will be top line data for the Covid portion of this trial ....not interim
The only interim data presented ..if any ...may be for the CAD portion ...ie is the median 1 yr data on over 1,000 patients tracking the 1 yr data on prior event patients in R-IT

Why do U have this idea that April 3 data is Interim data ?

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News